The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
There is no evidence that a senior Food and Drug Administration (FDA) worker was arrested after samples of the H5N1 bird flu virus were found in his fridge. The narrative stems from a website whose ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.
The new drug is intended for treatment of moderate to ... also applauded the approval of suzetrigine. "It has no sign of addiction, which makes it a hugely important new tool as we fight the ...
The FDA defines a Class 1 recall as “a situation in which there is a reasonable probability that the use of or exposure to a ...